Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

20.57
-0.9300-4.33%
Post-market: 20.570.00000.00%16:34 EDT
Volume:154.08K
Turnover:3.18M
Market Cap:1.39B
PE:-19.05
High:21.62
Open:21.60
Low:20.23
Close:21.50
52wk High:26.30
52wk Low:12.56
Shares:67.77M
Float Shares:17.44M
Volume Ratio:0.66
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0799
EPS(LYR):-1.0800
ROE:-74.45%
ROA:-42.37%
PB:17.28
PE(LYR):-19.05

Loading ...

Mar 16, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 19, 2019

Major Issues Report

Current report, item 5.02
Nov 07, 2019

Major Issues Report

Current report, items 2.02, 5.02, and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 11, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Sep 11, 2019

[Rev.]Quaterly Report

[Amend] Quarterly report [Sections 13 or 15(d)]
Sep 10, 2019

Correspondence

[Cover]Correspondence
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 08, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Major Issues Report

Current report, items 1.01, 2.03, 8.01, and 9.01
May 17, 2019

Major Issues Report

Current report, item 5.07
May 03, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 30, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Dec 17, 2018

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 21, 2018

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 02, 2018

Correspondence

[Cover]Correspondence